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 The corneal endothelium is a single layer of flattened
cells adhered to Descemet’s membrane. It forms a boundary
between the corneal stroma and the anterior chamber. The main
role of the corneal endothelium is to maintain corneal trans-
parency by regulating stromal hydration. Since endothelial cell
density naturally decreases with age, human corneal endothe-
lial cells (HCEC) are considered to be nonproliferative in vivo.
Joyce et al. [1-3] showed that HCEC in vivo are arrested in
the G1 phase of the cell cycle, while studies by Wilson et al.
[4,5] demonstrated that HCEC in vivo retain proliferative ca-
pacity.
Previous investigators have developed culture techniques
and medium formulation that promote consistent culture of
untransformed corneal endothelial cells from human donors
[6-11] or animals [12-17]. Effects of numerous growth-pro-
moting agents were tested using cultured HCEC. Samples et
al. [18] showed the effect on cell growth of serum, epidermal
growth factor (EGF), fibroblasts growth factor (FGF), nerve
growth factor (NGF), bovine pituitary extract (BPE), and en-
dothelial cell growth factor. Engelmann et al. [8] improved
their previously optimized medium [7] and reduced the serum
concentration down to 5% by adding ascorbic acid, insulin,
selenium, transferrin, lipids, and FGF. Joyce et al. [10,11] con-
firmed mitotic or morphologic changes in response to serum,
EGF, NGF, and BPE.
Animal models are required for preclinical studies. Be-
cause the biology of the eye of the pig is close to that of the
human in many respects [19], it would be important to be able
to cultivate porcine corneal endothelial cells (PCEC) in a
growth medium that allows rapid proliferation while keeping
a small cell size with a polygonal morphology at confluence.
Several investigators used PCEC cultures for in vitro studies
[20-27]. However, few have tested the stimulation of cell pro-
liferation by growth-promoting agents. To our knowledge, only
Lee et al. [14] improved the growth of PCEC cultures through
their tests of different concentrations of EGF and chondroitin
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Purpose: To optimize the growth condition of porcine corneal endothelial cells (PCEC), we evaluated the effect of
coculturing with a feeder layer (irradiated 3T3 fibroblasts) with the addition of various exogenous factors, such as epider-
mal growth factor (EGF), nerve growth factor (NGF), bovine pituitary extract (BPE), ascorbic acid, and chondroitin
sulfate, on cell proliferation, size, and morphology.
Methods: PCEC cultures were seeded at an initial cell density of 400 cells/cm2 in the presence or absence of 20,000
murine-irradiated 3T3 fibroblast/cm2 in the classic media Dulbecco’s Modified Eagle’s Medium (DMEM) supplemented
with 20% fetal bovine serum (FBS). Mean cell size and bromodeoxyuridine incorporation was assessed at various pas-
sages. Growth-promoting factors were studies by seeding PCEC at 8,000 cells/cm2 in DMEM with 20% FBS or Opti-
MEM I supplemented with 4% FBS and one of the following additives: EGF (0.5, 5, 25 ng/ml), NGF (5, 20, 50 ng/ml),
BPE (25, 50, 100, 200 µg/ml), ascorbic acid (10, 20, 40 µg/ml) and chondroitin sulfate (0.03, 0.08, 1.6%), alone or in
combination. Cell number, size and morphology of PCEC were assessed on different cell populations. Each experiment
was repeated at least twice in three sets. In some cases, cell cultures were maintained after confluence to observe post-
confluence changes in cell morphology.
Results: Co-cultures of PCEC grown in DMEM 20% FBS with a 3T3 feeder layer improved the preservation of small
polygonal cell shape. EGF, NGF, and chondroitin sulfate did not induce proliferation above basal level nor did these
additives help maintain a small size. However, chondroitin sulfate did help preserve a good morphology. BPE and ascor-
bic acid had dose-dependent effects on proliferation. The combination of BPE, chondroitin sulfate, and ascorbic acid
significantly increased cell numbers above those achieved with serum alone. No noticeable changes were observed when
PCEC were cocultured with a 3T3 feeder layer in the final selected medium.
Conclusions: Improvements have been made for the culture of PCEC. The final selected medium consistently allowed the
growth of a contact-inhibited cell monolayer of small, polygonal-shaped cells.
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sulfate. Thus, the aim of this study was to further optimize the
growth medium used for the culture of PCEC.
The coculture with a feeder layer may help in the initia-
tion of cultures from a low number of cells or from cells with
low proliferative ability. The first use of irradiated 3T3 as a
feeder layer was reported 30 years ago, when they were shown
to favor the formation of cell colonies from diluted human
epidermal keratinocytes in culture [28]. This technique led to
the clinical application of cultured epidermis for the treatment
of burn patients [29,30]. These days, feeder layer of irradiated
3T3 cells are used to coculture many different cell types, in-
cluding epithelial cells from skin [31] and cornea [32-36].
Alternatively, the growth of cells may be stimulated with ad-
ditives to culture media. In this study, we evaluated the mi-
totic changes of PCEC in response to stimulation by growth-
promoting agents, such as serum, EGF, NGF, BPE, ascorbic
acid, and chondroitin sulfate.
METHODS
Porcine corneal endothelial cell isolation:  The use of animal
cells in this study followed the guidelines set by our institu-
tion for animal cell research. Porcine eyes were obtained from
a local slaughterhouse within 24 h after death. Corneas were
dissected out of the globes using a curved scissors (Storz, St.
Louis, MO) and washed several times in Dulbecco’s Modi-
fied Eagle’s Medium (DMEM; Invitrogen, Burlington, Ontario,
Canada) containing 100 UI/ml penicillin (Sigma, Oakville,
Ontario, Canada) and 25 µg/ml gentamicin (Schering Canada,
Pointe-Claire, Québec, Canada). Corneas were incubated 30
min at 37 °C in 2.5 mg/ml dispase (Roche, Laval, Québec,
Canada). The loosened Descemet’s membrane was then peeled
off, and endothelial cells were isolated per guidelines described
in Zhu et al. [10]. Pooled cells were then centrifuged, resus-
pended in fresh medium, counted, and plated on dishes coated
with fibronectin, collagen, and albumin (FNC; Athena Enzyme
Systems, Baltimore, MD) according to the manufacturer’s in-
structions. The FNC coating was used for primary cultures
(P0) only and was not used for subsequent passaged cells. Low
passaged cells were routinely cryopreserved in 90% FBS
(Hyclone, Logan, UT)/10% dimethylsulfoxide (DMSO;
Sigma). Unfrozen cells were allowed at least one passage be-
fore their use in experiments. After thawing, they exhibited
normal cell proliferation and morphology (data not shown).
For each study, a Student’s t-test was performed to analyze
statistical significance with p<0.001 considered to be signifi-
cant.
Effect of coculture:  Freshly isolated PCEC in primary
culture (P0) seeded at 400 cells/cm2 were cultured in DMEM
20% FBS or in the selected medium in plastic flasks with or
without a feeder layer of irradiated murine 3T3 cells (20,000
3T3/cm2). Cells were trypsinized at 60-80% confluence and
subcultured in the same conditions. Cell number and mean
cell size was assessed using a cell counter and particle size
analyzer (Beckman Coulter Z2, Mississauga, Ontario, Canada)
set to evaluate mean cell size of cells counted between 7.9 and
24.1 µm. Experiments were done three times in triplicate us-
ing different pooled cells, and three different counts were done
for each sample. Other cultures were maintained one week
after confluence to document their morphology at post-
confluence. For each condition, three other flasks were used
for bromodeoxyuridine (BrdU; Sigma) analysis (Figure 1A).
Bromodeoxyuridine analysis:  The 60-80% confluent cul-
tures were exposed to medium containing 10 µM BrdU for 45
min at 37 °C. The cultures were then rinsed, trypsinized, and
the cells fixed in 70% ethanol. Cells were kept at -20 °C until
staining. Fixed PCEC were stained with a fluorescein
isothiocyanate (FITC)-conjugated mouse anti-BrdU mono-
clonal antibody (clone 3D4; BD Pharmingen, Oakville,
Ontario, Canada) as well as propidium iodide (Sigma) fol-
lowing a modified version of a method developed by Van Erp
et al. [37]. Stained cells were analyzed by flow cytometry on
a FACScalibur (Becton Dickinson) and analyzed using the
program CellQuestPro (Becton Dickinson). For negative con-
trol, cells were stained with FITC-conjugated mouse IgG1κ
monoclonal isotype control antibody (clone MOPC-21; BD
Pharmingen).
Effect of basal media:  PCEC were seeded at 12,000 cells/
cm2 in six-well plates either in DMEM or Opti-MEM I
(Invitrogen), both supplemented with 5% FBS. Triplicate wells
were counted twice as previously described from day 1 to day
6 (Figure 1B). Opti-MEM I (Invitrogen) is a modification of
Eagles Minimum Essential Medium, buffered with HEPES
and sodium bicarbonate (2.4 g/l) and supplemented with hy-
poxanthine, thymidine, sodium pyruvate, L-glutamine, and
trace elements. Calcium chloride (0.2 g/l) was added in the
Opti-MEM I solution.
Effect of growth-promoting additives:  PCEC routinely
passaged at 8,000 cells/cm2 were cultured in DMEM 20% FBS
and switched to Opti-MEM I (Invitrogen) supplemented with
0.2 g/l CaCl2 and 4% FBS and antibiotics overnight. PCEC
were then trypsinized and plated at 8,000 cells/cm2 and cul-
tured in the presence of the following additives (used alone or
in combination): EGF (0.5, 5, and 25 ng/ml; Austral
Biologicals, San Ramon, CA), NGF from mouse submaxil-
laries (5, 20, 50 ng/ml; Biomedical Technologies, Stoughton,
MA), BPE (25, 50, 100, and 200 µg/ml; Biomedical Tech-
nologies), ascorbic acid (10, 20, and 40 µg/ml), and chon-
droitin sulfate A sodium salt from bovine trachea (0.03, 0.08,
and 1.6%; Sigma). Cell number, size and morphology were
assessed on day 4. Each condition was done at least twice in
triplicate using different pooled cells, and each sample was
counted three times using a cell counter and particle size ana-
lyzer that was set to evaluate mean cell size of cells counted
between 7.9 and 24.1 µm. Ascorbic acid and chondroitin sul-
fate were added fresh at every medium change. Also, the me-
dium containing 50 µg/ml BPE, 20 µg/ml ascorbic acid, and
0.08% chondroitin sulfate was tested in the presence (4% and
8%) or absence of serum as previously described. Cells grown
without serum were incubated overnight in 4% serum to al-
low cell adhesion (Figure 1C).
RESULTS
Effect of coculture:  We assessed the effect of coculturing PCEC
with irradiated 3T3 fibroblasts on mean cell size, morphol-
525ogy, and proliferation using BrdU incorporation. PCEC were
cultured in DMEM 20% FBS with or without a feeder layer.
Endothelial cells cultured in DMEM 20% FBS with a feeder
layer retained their distinctive endothelial morphology in ad-
dition to their small size longer than cultures without a feeder
layer. At the low seeding density of 400 cells/cm2, the cultures
at passage 1 (P1) lost their uniformity in size and morphology
(Figure 2A,C), whereas cells cultured with a feeder layer at
the same density also at P1 retained their small size (Figure
2A) and their typical polygonal morphology (Figure 2D). BrdU
analysis demonstrated that cells in both conditions incorpo-
rated BrdU at a similar percentage, indicating that the feeder
layer did not affect the growth rate (Figure 2B).
Effect of basal media:  We first evaluated the growth re-
sponse of PCEC cultured with the classic DMEM or with the
Opti-MEM I. The same cell populations and the same serum
concentration used in both cases permitted a direct compari-
son of the number of cells after various days in culture. Opti-
MEM I induced a statistically significant greater number of
cells (after 2, 3, 4, 5, and 6 days) than that of the DMEM
(Figure 3). Therefore, Opti-MEM I was used in other experi-
ments for the optimization of the growth medium for PCEC.
Effect of growth-promoting additives:  To study the dose-
dependent effect of several growth-promoting factors, PCEC
were cultured in a growth medium containing a reduced-se-
rum concentration (Opti-MEM I 4% FBS). The effect of EGF,
NGF, BPE, chondroitin sulfate, and ascorbic acid were tested
on the proliferative response, morphology, and cell size of
PCEC (Figure 4). Figure 4B shows that EGF at concentra-
tions of 0.5 and 25 ng/ml and all concentrations tested for
NGF had no significant stimulatory effect on the proliferation
of PCEC above basal levels nor did they help maintain a small
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Figure 1. Flow diagram of the experimen-
tal protocol.  A: Effect of coculture.
Freshly isolated porcine corneal endot-
helial cells (PCEC) in primary culture
(P0) seeded at 400 cells/cm2 were cul-
tured in Dulbecco’s Modified Eagle’s
Medium (DMEM) 20% fetal bovine se-
rum (FBS) or in the selected medium with
or without a feeder layer of irradiated
murine 3T3 cells. Cells were trypsinized
at 60-80% confluence and subcultured in
the same conditions. Cell number, mean
cell size, and bromodeoxyuridine (BrdU)
analysis were assessed on the pre-
confluent cells. Other cultures were main-
tained one week after confluence to docu-
ment their morphology at post-
confluence. B: Effect of basal media.
PCEC were seeded at 12,000 cells/cm2
either in DMEM or Opti-MEM I, both
supplemented with 5% FBS. Cells of
each well were counted from day 1 to day
6. C: Effect of growth promoting addi-
tives. PCEC seeded at 8,000 cells/cm2
were cultured in DMEM 20% FBS and
switched to Opti-MEM I 4% FBS over-
night. PCEC were then trypsinized and
plated at 8,000 cells/cm2 and cultured in
the presence of the following additives
(used alone or in combination): epider-
mal growth factor (EGF), nerve growth
factor (NGF), bovine pituitary extract
(BPE), ascorbic acid (AA), and chon-
droitin sulfate (CDS). Cell number, size,
and morphology were assessed on day 4.
Also, the selected medium containing
BPE, CDS, and AA was tested in the pres-
ence (4% and 8%) or absence of serum.
See the methods section for further de-
tails.
526mean cell size. A concentration of 5 ng/ml had a small but
statistically significant increase in cell number, however this
concentration did not have a significant effect on mean cell
size and morphology. Therefore, EGF and NGF were not kept
for the final selected medium.
BPE shows a dose-dependent effect on PCEC growth and
mean cell size as shown in Figure 4A and Figure 4B. The high-
est number and the smallest cells were obtained with a BPE
concentration of 200 µg/ml. However, high concentrations of
BPE greatly changed the morphology of PCEC. Cells at 200
µg/ml BPE had a fibroblast-like morphology (Figure 4D). In
contrast, 50 µg/ml BPE preserved an adequate cell morphol-
ogy. It was thus chosen as the optimal BPE concentration for
PCEC cultures (Figure 4C).
Following the addition of freshly prepared solutions,
ascorbic acid had a dose-dependent effect on cell growth as
shown in Figure 4B. The highest concentration of ascorbic
acid tested (40 µg/ml) yielded the highest cell number and the
smallest cells. However, the typical endothelial cell morphol-
ogy was more closely achieved with 20 µg/ml (Figure 4E).
For PCEC, 0.03 and 0.08% chondroitin sulfate reduced
cell growth by, respectively 1.4 and 1.5 times, and 1.6% dra-
matically reduced (3.6X) the growth of PCEC compared to
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Figure 2. Effect of coculturing por-
cine corneal endothelial cells
(PCEC) with a feeder layer of irra-
diated 3T3 cells grown in
Dulbecco’s Modified Eagle’s Me-
dium (DMEM) 20% fetal bovine
serum (FBS).  A: Mean cell size of
PCEC cultured at different passages
(P) after seeding at the very low cell
density of 400 cells/cm2 without a
feeder layer (DMEM) and with a
feeder layer (DMEM+3T3). B: Per-
centage of bromodeoxyuridine
(BrdU) incorporation of PCEC
seeded at 400 cells/cm2 at P1 cul-
tured without a feeder layer
(DMEM) and with a feeder layer
(DMEM+3T3). The results are the
mean±SD. Student t-test performed
between P0 and P1 (the asterisk in-
dicates a p<0.001). Morphology of
PCEC (P1) seeded at 400 cells/cm2
and cultured without a feeder layer
(C) and with a feeder layer (D). The
scale bar equals 100 µm. Note the
smaller size of porcine endothelial
cells in the presence of a feeder
layer.
Figure 3. Effect of basal media.  Cell counts of PCEC at various days
post-seeding. Open circles=cell counts of PCEC grown in Dulbecco’s
Modified Eagle’s Medium (DMEM) supplemented with 5% fetal
bovine serum (FBS). Dark circles=cell counts of PCEC grown in
Opti-MEM I supplemented with 5% FBS. The results are plotted as
the mean±SD. Student t-test performed between DMEM and Opti-
MEM I (the asterisk indicates a p<0.001).
527the control culture (Figure 4B). A concentration of 0.08% chon-
droitin sulfate was kept in the final selected medium because
it was shown to keep cells growing in tightly packed units,
thus aiding cell morphology (Figure 4F).
The medium containing the combined factors conducive
to the best growth, mean cell size, and morphology was tested
(Figure 5) in the presence or absence of serum. Culturing PCEC
in Opti-MEM I supplemented with 0%, 4%, or 8% FBS with
50 µg/ml BPE, 20 µg/ml ascorbic acid and 0.08% chondroitin
sulfate resulted in a significant increase in cell number when
compared to cells grown in Opti-MEM I only (0% FBS) or
with serum alone (4% or 8% FBS; Figure 5B). Adding the
supplements in 0% serum resulted in a 4.1 fold increase in
cell number, and the total cell number in the supplemented
0% serum medium was similar to that achieved with DMEM
20% FBS. When added in 4% and 8% serum, the supplements
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Figure 4. Effect of different additives on cell number, size, and morphology of porcine corneal endothelial cells (PCEC).  Representative
results of the dose-dependent effect of various growth-promoting factors. PCEC were cultured in Opti-MEM I 4% fetal bovine serum (FBS)
and one of the following factors: epidermal growth factor (EGF; 0.5, 5, and 25 ng/ml), nerve growth factor (NGF; 5, 20, and 50 ng/ml), bovine
pituitary extract (BPE; 25, 50, 100, and 200 µg/ml), chondroitin sulfate (CDS; 0.03, 0.08, and 1.6%) and ascorbic acid (AA; 10, 20, 40 µg/ml).
A shows the mean cell size. B: Number of cells/cm2. The results are the mean±SD. The asterisk indicates a p<0.001 compared to Opti-MEM
I 4% FBS (cell number and cell size). Morphology at day 4 of PCEC grown in C BPE 50 µg/ml, D BPE 200 µg/ml, E ascorbic acid 20 µg/ml,
and F chondroitin sulfate 0.08%. The scale bar is equal to 100 µm.
528increased cell number 2.1 and 2.4 times, respectively. Adding
the supplements also resulted in a smaller mean cell size. As
shown in Figure 5C, PCEC grown in the classic DMEM 20%
FBS formed a monolayer of cells harboring different shapes
including some that were elongated. However, PCEC grown
in our selected medium (8% serum and additives) formed a
uniform monolayer of tightly packed cuboidal cells (Figure
5D), indicating that they harbor a morphology similar to the
normal endothelial morphology found in vivo.
Selected medium and 3T3 coculture:  We then evaluated
the effect of coculturing PCEC with a feeder layer of irradi-
ated 3T3 cells grown in this selected medium with a seeding
cell density of 400 cells/cm2. As shown in Figure 6A, mean
cell size at P1 remained small regardless of the presence of
3T3 cells. Morphology was similar (Figure 6C, 6D), as was
the percentage of BrdU incorporation (Figure 6B). Thus, no
significant effect of the 3T3 feeder layer was found when PCEC
were grown in our selected medium.
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Figure 5. Effect of different culture
media formulations on cell number,
size, and morphology of porcine
corneal endothelial cells (PCEC).
Representative results of the addi-
tive effect of 50 µg/ml bovine pitu-
itary extract (BPE), 0.08% chon-
droitin sulfate (0.08 CDS) and 20
µg/ml ascorbic acid (20AA) on (A)
mean cell size and (B) cell number
at day 4 on PCEC grown in Opti-
MEM I supplemented with 0, 4, or
8% fetal bovine serum (FBS), and
compared to the classic Dulbecco’s
Modified Eagle’s Medium
(DMEM) 20% FBS (dashed bar
graph; mean±SD). The asterisk in-
dicates a p<0.001 compared to
DMEM 20% FBS (cell number and
cell size). Morphology of PCEC
grown in C DMEM 20% FBS or D
the selected medium, consisting of
Opti-MEM I supplemented with 8%
FBS, 50 µg/ml BPE, 0.08% chon-
droitin sulfate and 20 µg/ml ascor-
bic acid. Cells were left in culture
one week passed confluence to as-
sess cell morphology of post-
confluent cultures. The scale bar is
equal to 100 µm. Note that in (C)
endothelial cells are elongated and
of different size whereas in (D) they
are small and cuboidal cells and
have a morphology more character-
istic of native cells.
529DISCUSSION
 Since the first cell culture of corneal endothelial cells [38],
many investigators have attempted to improve growth culture
conditions in order to maximally amplify cells while retain-
ing morphology and function [6-8,10,11,17,18,39]. One way
of improving culture conditions is to grow them in coculture
with an irradiated feeder layer. The addition of a feeder layer
of irradiated fibroblasts supports the formation of colonies from
a single cutaneous epithelial cell [28,40]. This powerful method
is now applied for the expansion of various cell types for in
vitro purposes and clinical applications of cultured epidermis
and cornea [29,30,33-36]. Since corneal endothelial cells are
in close contact with the corneal stroma through Descemet’s
membrane, it has been speculated that keratocytes secrete
growth factor or nutrients that favor the well being of corneal
endothelial cells. When cells are grown in cocultures, fibro-
blasts are not proliferative (since irradiated) but are still able
to secrete nutrients or growth factors. Their beneficial influ-
ence is well known for the culture of epithelial cells from skin
[28,40] and cornea [32-36]. We have shown that coculturing
PCEC with irradiated murine fibroblasts does not affect pro-
liferation. Furthermore, a new media supplemented with se-
rum and additives was identified which allows PCEC to re-
tain their small cell size and morphology on plastic as well as
in DMEM 20% FBS in coculture with irradiated fibroblasts.
For cells to grow in vitro, they require a complex mixture
of nutrients and growth factors which contributes to an ad-
equate physiological environment. A complete analysis de-
mands well characterized assay systems that allow the dis-
crimination of a single component’s contribution to cell growth.
In this study, we used direct cell counts to determine the rela-
tive effect of various growth-promoting agents on PCEC, as
was previously done by many investigators for the optimiza-
tion of corneal endothelial cell cultures [10,11].
EGF was tested because of its known positive effect on
corneal wound healing in ex vivo models and in culture for
human [10,11,15,41,42] and porcine [14] cells. Mixed results
have been previously reported on the effect of EGF on cor-
neal endothelial cell growth. Some studies show an increase
in proliferation for bovine [12,17], rabbit [43], primates [44],
and humans [18,45], while others show that EGF either has
no effect [30] (human) or has an inhibitory effect [46] (rabbit)
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Figure 6. Effect of coculturing
porcine corneal endothelial
cells (PCEC) with a feeder
layer of irradiated 3T3 cells
grown in our selected medium.
A: Mean cell size of PCEC
cultured at different passages
(P) after seeding at the very
low cell density of 400 cells/
cm2 without a feeder layer (Se-
lected) and with a feeder layer
(Selected+3T3). B: Percentage
of bromodeoxyuridine (BrdU)
incorporation of PCEC seeded
at 400 cells/cm2 at P1 cultured
without a feeder layer (Se-
lected) and with a feeder layer
(Selected+3T3; mean±SD).
The student’s t-test performed
shows that there is no statisti-
cally significant difference be-
tween P0 and P1 (p<0.001).
Morphology of PCEC (P1)
seeded at 400 cells/cm2 and
cultured without a feeder layer
(C) and with a feeder layer (D),
both grown in the selected
medium, consisting of Opti-
MEM I supplemented with 8%
fetal bovine serum (FBS), 50
µg/ml bovine pituitary extract
(BPE), 0.08% chondroitin sul-
fate and 20 µg/ml ascorbic
acid. The scale bar is equal to
100 µm.
530on cell growth. EGF can have a different effect, depending on
the age of the donor cells. Recent studies using cultured HCEC
indicated that EGF has a dose-dependent effect on prolifera-
tion in a range of 0.05 to 5 ng/ml, with a peak cell count at 5
ng/ml [10,11]. EGF moderately stimulated proliferation in cells
from younger human donors, but did not consistently stimu-
lated proliferation in cells from older donors [10,11]. Using
PCEC, a previous study showed that low concentrations of
EGF (10 ng/ml) had no significant stimulatory effect while
high concentrations (100 ng/ml) stimulated cell growth [14].
Our results are in accordance with this study since the low
concentrations of 0.5 to 25 ng/ml did not considerably increase
PCEC cell numbers.
NGF is secreted in the aqueous humor [47,48]. Thus, it
could influence endothelial cells since immunochemistry stud-
ies indicated that HCEC express TrkA [49], the high affinity
receptor for NGF [50]. In bovine corneal endothelial cell cul-
tures, concentrations of 1, 10, and 100 ng/ml of NGF failed to
significantly stimulate DNA synthesis [17]. A study that used
human cells reported that NGF (0.2-200 ng/ml) did not stimu-
late proliferation, but appeared to have a positive effect on
cell morphology [10]. With PCEC, we did not see an effect of
this growth factor on proliferation, mean cell size, or mor-
phology.
Of the growth-promoting additives tested in this study,
only BPE and ascorbic acid demonstrated a positive effect on
cell growth and mean cell size. BPE is a broadly used supple-
ment to culture a variety of epithelial and endothelial cells. It
is routinely used as a mitogenic supplement in serum-free
growth medium. In addition to its mitogenic activity, BPE
contains a variety of growth factors and hormones with re-
ported antioxidant activity [51]. Previous studies have shown
a positive effect of BPE on cultured corneal endothelial cells
from human origin [10,11]. In this study, the effective con-
centrations of BPE were between 25-200 µg/ml, which is con-
sistent with a previous study done with HCEC showing that
BPE induced a dose-dependent response at concentrations of
0.1 to 100 µg/ml, with a peak cell number reported at 100 µg/
ml [10].
Ascorbic acid is an important water-soluble antioxidant
found in numerous media. Ascorbic acid (75 µg/ml) added
daily to cultured rabbit corneal endothelial cells had an in-
hibitory effect on cell growth [46]. However, Zhu and Joyce
[10,11] routinely included ascorbic acid in their optimized
growth medium for HCEC cultures. Ascorbic acid was previ-
ously found to have a dose-dependent increase in cell number
on human cell cultures at concentrations of 6.25 to 25 µg/ml
[8]. Further increases in ascorbic acid concentration appar-
ently reversed this stimulation. A concentration of 20 µg/ml
of ascorbic acid maximally stimulated growth [8]. Our results
showed a positive effect of 10-40 µg/ml ascorbic acid on the
growth of PCEC and are consistent with these previous stud-
ies.
Chondroitin sulfate is a mucopolysaccharide with an ap-
proximate molecular weight of 50,000 Da. It is found in trace
amounts in the human corneal stromal layer [52]. The endot-
helial protective effect of chondroitin sulfate in the preserva-
tion media for cornea in eye banks has been proven by many
investigators [53-58], however, reports concerning its effects
on corneal endothelial cell cultures are rare. A concentration
of 0.08% (0.8 mg/ml) was found to have a positive effect on
proliferation and also prevented enlargement of HCEC cul-
tures [6]. Yue et al. [39] showed that low concentrations (100
µg/ml to 1 mg/ml) of chondroitin sulfate had little effect on
proliferation. However, high concentrations (13.5 and 25 mg/
ml) significantly promoted HCEC growth during the 1- to 2-
week incubation period. A study using PCEC demonstrated
the addition of 1 mg/ml chondroitin sulfate to the growth me-
dium had no effect on proliferation, and that higher concen-
trations (25 mg/ml) resulted in inhibition of proliferation [14].
In this study we showed chondroitin sulfate decreased prolif-
eration of PCEC compared to control. However, we kept some
chondroitin sulfate in the selected medium because of its ben-
eficial aspect for overall cell morphology.
Culturing PCEC in Opti-MEM I supplemented with 8%
FBS, 50 µg/ml BPE, 20 µg/ml ascorbic acid, and 0.08% chon-
droitin sulfate resulted in a significant increase in cell prolif-
eration when compared to cells grown in Opti-MEM I supple-
mented with 8% FBS alone (Figure 2B). In confluent cultures,
the shape of endothelial cells also provides important infor-
mation regarding the overall health of the monolayer. Growth
in our selected culture medium (Opti-MEM I supplemented
with 8% FBS, 50 µg/ml BPE, 20 µg/ml ascorbic acid, and
0.08% chondroitin sulfate) consistently generated cultures of
small, polygonal-shaped cells, a morphology closer to that of
the endothelium monolayer in vivo. Taken together, our re-
sults present species-specific effects of various supplements.
For example, 0.5 to 25 ng/ml EGF did not affect proliferation
of PCEC, whereas this growth factor has a dose-dependent
effect on proliferation of HCEC in a range of 0.05 to 5 ng/ml
[10,11]. Such species-specific differences are frequently found
in cell cultures of other cell types, such as skin epithelial cells.
For instance, high concentrations of calcium inhibits prolif-
eration of mouse epidermal cells [59], but does not affect pro-
liferation of human epidermal cells [30].
In summary, improvements have been made for the cul-
ture of PCEC. The present study compared the effect of sev-
eral growth-promoting agents on proliferation, mean cell size,
and morphology of PCEC. EGF, NGF, and chondroitin sul-
fate did not induce proliferation above basal levels. BPE and
ascorbic acid stimulated growth, the combination of which
had an additive effect, significantly increasing cell numbers
above that achieved with serum alone. This study showed that
PCEC cultures can be initiated with a small number of viable
cells, such as would be the case from a small biopsy for the
culture of autologous cells. The selected medium allowed the
production of a contact inhibited cell monolayer that can be
grown in sufficient quantities to permit a high cell density seed-
ing of these cells on a stroma for the reconstruction of an au-
tologous posterior cornea in the pig model. Further studies
will be required to evaluate the efficiency of the reconstructed
corneas to support vision in the pig model following trans-
plantation of these reconstructed porcine corneas before de-
veloping clinical applications.
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